ASTRO

This page includes the latest news from the American Society of Radiation Oncology (ASTRO), including news and video coverage from the society's annual meeting. ASTRO is the premier radiation oncology society in the world, with more than 10,000 members who are physicians, nurses, biologist, physicists, radiation therapists, dosimetrists and other healthcare professionals who specialize in treating patients with radiation therapy. 

FDA Clears Advancements for Viewray MRIdian Radiation Therapy System
Technology | Image Guided Radiation Therapy (IGRT) | February 21, 2019
February 21, 2019 — ViewRay Inc. received 510(k) clearance from the U.S. Food and Drug Administration (FDA) to market...
New Targeted Therapy for Recurrent Brain Tumors Implanted for First Time
News | Radiation Therapy | February 15, 2019
February 15, 2019 – University of Minnesota Health (M Health) is the first in the United States to begin offering...
Elekta Unity MR-Linac Earns FDA Clearance
Technology | Image Guided Radiation Therapy (IGRT) | February 07, 2019
February 7, 2019 — The Elekta Unity magnetic resonance radiation therapy (MR/RT) system recently received 510(k)...
Stereotactic Radiotherapy Improves Long-Term Survival in Stage-IV Cancers
News | Stereotactic Body Radiation Therapy (SBRT) | January 31, 2019
January 31, 2019 — The first report from a phase II, multi-center clinical trial indicates stereotactic radiation can...
Philips Collaborates With MIM Software on Radiation Therapy Treatment Planning
News | Treatment Planning | January 31, 2019
January 31, 2019 — Philips announced a collaboration with imaging solutions provider MIM Software Inc. to improve...
Laurent Levy, CEO of Nanobiotix, explains the use of his company’s nanoparticles to enhance the radiation sensitivity of tumor tissue to improve patient outcomes

Laurent Levy, CEO of Nanobiotix, explains the use of his company’s nanoparticles to enhance the radiation sensitivity of tumor tissue to improve patient outcomes. The metallic-based nanoparticles show up on CT scans so it can be used as a permanent fiduciary marker to track tumor response. The images show the initial tumor and enhancement areas due to the nanoparticles and the resulting outcomes following treatment. Photo by Dave Fornell

Feature | Radiation Oncology | January 30, 2019 | By Dave Fornell
Artificial intelligence (AI) has been the hot topic discussed at all trade shows, and the 2018 American Society for...
Sponsored Content | Videos | Radiation Therapy | January 18, 2019
Join Chris Toth, president of Varian’s Oncology Systems business, for a look at product introductions for 2018 plus a...
Brachytherapy Alone Superior Treatment for Intermediate-Risk Prostate Cancer
News | Brachytherapy Systems | January 04, 2019
January 4, 2018 — Patient-reported outcomes (PROs) indicated a significantly different clinician and patient-reported...
Videos | Radiation Therapy | December 06, 2018
Radiation therapy has become increasingly effective and safe as vendors continue to innovate technologies that benefit...
Sponsored Content | Videos | Radiation Oncology | November 30, 2018
Accuray's philosophy is to personalize treatments to exactly fit the patient. Senior Director of Marketing Andrew Delao...
Immune Inflammatory Levels Linked to Disease-Free Survival in Prostate Cancer
News | Prostate Cancer | November 19, 2018
November 19, 2018 — Data from a validation study of a high-risk prostate cancer trial suggests that higher levels of...
ASTRO has worked for many years to craft a viable payment model that would stabilize payments, drive adherence to nationally-recognized clinical guidelines and improve patient care.
News | ASTRO | November 08, 2018
Following comments today from Alex Azar, the Secretary of Health and Human Services, on an alternative payment model...
Videos | ASTRO | November 08, 2018
ITN Editor Dave Fornell took a tour of some of the most innovative technologies on display on the expo floor at the ...
Laurent Levy, CEO of Nanobiotix, explains the use of his company's nanoparticles to enhance the radiation sensitivity of tumor tissue to improve patient outcomes.

Laurent Levy, CEO of Nanobiotix, explains the use of his company's nanoparticles to enhance the radiation sensitivity of tumor tissue to improve patient outcomes. The images show the initial tumor and enhancement areas due to the nanoparticles and the resulting outcomes following treatment.

Blog | ASTRO | November 08, 2018 | Dave Fornell, Editor
Here are a few of the radiation oncology technology advancement takeaways seen at the 2018 American Society for...
The Fujifilm FCT Embrace CT System displayed for the first time at ASTRO 2018.
360 Photos | 360 View Photos | November 07, 2018
Fujifilm's first FDA-cleared computed tomography (CT) system, the FCT Embrace, at the American Society of Radiation...
This is the Siemens Magnetom Sola RT edition 1.5T MRI system optimized for radiation therapy displayed for the first time since gaining FDA clearance in 2018. It was displayed at the American Society for Radiotherapy and Oncology (ASTRO) 2018 annual meeting. Read more about this system at ASTRO 2018. #ASTRO18 #ASTRO2018
360 Photos | 360 View Photos | November 07, 2018
This is the Siemens Magnetom Sola RT edition 1.5T MRI system optimized for radiation therapy displayed for the first...
Videos | Brachytherapy Systems, Women's Healthcare | November 07, 2018
An interview with A. M. Niser Syed, M.D., medical director, radiation oncology and endocurietherapy, MemorialCare...
Videos | Radiation Oncology | November 07, 2018
Aadel Chaudhuri, M.D., assistant professor of radiation oncology, Washington University, St. Louis, Mo., explains his...
GE Healthcare Discovery RF Gen 2 system displayed at ASTRO 2018. It is a dedicated computed tomography (CT) scanner for radiation oncology
360 Photos | 360 View Photos | November 07, 2018
This is the GE Healthcare Discovery RF Gen 2 system displayed at the American Society for Radiotherapy and Oncology (...
Proton Therapy for Pediatric Brain Tumors Has Favorable Cognitive Outcomes
News | Proton Therapy | November 06, 2018
November 6, 2018 – Proton therapy treatment for pediatric brain tumor patients is associated with better neurocognitive...